

Investing.com
5957 Articles
Investing.com is a financial markets platform providing real-time data, quotes, charts, financial tools, breaking news and analysis across 250 exchanges around the world in 44 language editions. With more than 46 million monthly users, and over 400 million sessions, Investing.com is one of the top three global financial websites according to both SimilarWeb and Alexa.
Cava Group ticks higher on surprise profit, strong same-restaurant sales in Q4
Investing.com -- CAVA Group Inc (NYSE:CAVA) reported a surprise fourth-quarter profit on Tuesday and better-than-expected same-restaurant sales.The company's shares added 2% in premarket trading W
Feb 26, 2025

First Solar misses Q4 profit estimates, but revenue better-than-feared; stock up
Investing.com -- First Solar Inc (NASDAQ:FSLR) reported fourth-quarter earnings below Wall Street estimates on Tuesday but revenue came in better than feared. Shares of First Solar climbed around
Feb 26, 2025

Stellantis shares slide lower on soft H2 results, loose guidance
Investing.com -- Stellantis (NYSE:STLA) said on Wednesday it expects to return to revenue growth and generate positive cash flow in 2025, but the company’s shares fell on soft results for the second h
Feb 26, 2025

Block valuation now 'reflective of risks': Morgan Stanley
Morgan Stanley upgraded Block Inc. to Equal-Weight from Underweight in a note Tuesday, stating that the stock’s current valuation now adequately reflects key risks.
Feb 26, 2025

Supermicro stock surges after filing delayed reports
Supermicro (NASDAQ:SMCI) stock surged higher in after-hours trading Tuesday after the company filed its delayed financial reports.
Feb 26, 2025

Intuit fiscal Q2 results top estimates, reiterates FY guidance; lifts dividend
Investing.com - Intuit reported fiscal second-quarter results Tuesday that topped Wall Street estimates and reiterated its full-year guidance. Intuit Inc (NASDAQ:INTU) rose 3% in afterhours trad
Feb 25, 2025

Workday stock soars 8% on earnings beat, strong guidance
Investing.com -- Workday Inc (NASDAQ:WDAY) shares surged 8% after the AI-powered enterprise management platform reported fourth-quarter earnings and revenue that exceeded analyst expectations, whi
Feb 25, 2025

Wall Street bullish on Metsera following January IPO on obesity drug pipeline
Investing.com -- Wall Street analysts initiated coverage on Metsera with bullish outlook given the biotech firm’s differentiated obesity drug pipeline and potential for significant upside. Metsera is
Feb 25, 2025

Lilly unveils higher vial doses of obesity drug that are cheaper than injector pen
Investing.com - Eli Lilly (NYSE:LLY) announced on Tuesday that it would begin selling 7.5 milligram and 10 milligram single-dose vials of its Zepbound weight-loss drug at a roughly $150 discount to it
Feb 25, 2025

Paypal shares up after earnings outlook
Investing.com -- PayPal (NASDAQ:PYPL) shares rose approximately 3% in premarket trading Tuesday after the company outlined its medium-term growth targets for 2025 to 2027.The outlook comes alongside a
Feb 25, 2025

Novo shares rise as HIMS halt sales of some obesity drugs
Novo Nordisk shares climbed more than 3% premarket on Tuesday after Hims&Hers Health announced it may no longer sell compounded versions of semaglutide, the active ingredient in Novo’s weight-loss drugs.
Feb 25, 2025

Donut chain Krispy Kreme unveils disappointing guidance, sending shares tumbling
Investing.com - Krispy Kreme (NASDAQ:DNUT) shares tumbled by more than 11% in premarket U.S. trading on Tuesday after the donut maker's annual sales and profit guidance missed analysts' expectatio
Feb 25, 2025

Alibaba, US-listed Chinese stocks rebound after sharp Monday sell-off
Investing.com -- US-listed Chinese stocks rebounded on Tuesday, with Alibaba (NYSE:BABA) gaining more than 4% in premarket trading after suffering its biggest one-day drop since 2022.
The KraneShares CSI China Internet ETF (NYSE:KWEB) rose 1% as of 05:36 ET in New York, while Alibaba recovered from
Feb 25, 2025

Hims&Hers flags it may halt sales of compounded weight-loss drug
Investing.com - Hims&Hers said on Monday that it may stop selling legal copies of a popular weight-loss drug made by Denmark's Novo Nordisk (NYSE:NVO), sending shares in the U.S. telehealth firm s
Feb 25, 2025

Crypto stock including MicroStrategy, Coinbase, Riot fall after BTC below $90k
Investing.com -- Crypto-related stocks slumped in premarket trading Tuesday following a sharp sell-off in Bitcoin and broader crypto markets.The world’s largest cryptocurrency fell over 8% to $87,792
Feb 25, 2025

Cleveland-Cliffs shares down on wider-than-expected loss, revenue miss
Investing.com -- Cleveland-Cliffs Inc (NYSE:CLF) posted a wider-than-expected fourth-quarter loss, also revenue came in below Wall Street estimates, sending its shares down more than 3% in premarket t
Feb 25, 2025

Zoom beats Q4 profit estimates, revenue in-line; shares down on guidance
Investing.com -- Zoom Video Communications Inc (NASDAQ:ZM) reported better-than-expected fourth-quarter earnings of fiscal 2025, but shares were down around 3% in premarket trading Tuesday as its
Feb 25, 2025

European markets mixed as Germany's economy contracts; Unilever CEO steps down
Investing.com -- European markets traded in mixed fashion on Tuesday, reflecting cautious market sentiment. At 03:10 ET (08:10 GMT), the U.K.’s FTSE 100 rose by 0.3%, while Germany’s DAX fell by 0.1%
Feb 25, 2025

Unilever CEO Hein Schumacher to step down
Investing.com -- Unilever PLC (LON:ULVR) said on Tuesday that its Chief Executive Officer Hein Schumacher, is set to leave the company, in a surprise move.The consumer goods giant said that Schuma
Feb 25, 2025

UBS upgrades XPeng as investors now willing to assign some AI value potential
Investing.com -- UBS analysts upgraded XPeng (NYSE:XPEV) to Neutral on Monday, citing growing investor willingness to attribute value to the company’s artificial intelligence (AI) initiatives.
Feb 25, 2025


